Journal of International Oncology ›› 2019, Vol. 46 ›› Issue (6): 374-377.doi: 10.3760/cma.j.issn.1673-422X.2019.06.013

Previous Articles     Next Articles

Application of metronomic chemotherapy in the treatment of advanced nonsmall cell lung cancer

Zhu Qingqing1,2, Xie Chao2, Song Bao3, Zhang Qiujing1,2, Liu Jie2   

  1. 1School of Medicine and Life Sciences, University of JinanShandong Academy of Medical Sciences, Jinan 250022, China; 2Department of Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan 250117, China; 3Basic Laboratory, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan 250117, China
  • Online:2019-06-08 Published:2019-07-11
  • Contact: Liu Jie, Email: lj691012@126.com E-mail:lj691012@126.com

Abstract: Metronomic chemotherapy is a brandnew and multitarget chemotherapy strategy. Totally different from the traditional chemotherapy, metronomic chemotherapy can exert synergistic and durable antitumor effects via multiple mechanisms, including cytotoxic effect, antiangiogenesis, immune regulation and so on. Single and combined therapy modes of metronomic oral vinorelbine have good curative effects and safeties for the treatment of advanced nonsmall cell lung cancer. With the indepth understanding of metronomic chemotherapy, it will certainly become an important treatment mode for advanced nonsmall cell lung cancer.

Key words: Carcinoma, non-small-cell lung, Chemoradiotherapy, Drug therapy, combination, Metronomic chemotherapy, Vinorelbine